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Summary: The Drosophila homeobox gene tinman plays
a critical role in subdividing the early mesoderm. In par-
ticular, tinman is absolutely required for formation of the
heart and visceral mesoderm. tinman expression is ini-
tiated throughout the mesoderm of the trunk region un-
der the control of the bHLH transcription factor encoded
by the twist gene, a determinant of all mesoderm. Later,
tinman expression is restricted to the dorsal portion of
the mesoderm, a process that is directed by decapen-
taplegic (dpp) whose product (a TGF-b-related protein)
is secreted by the overlaying ectoderm. Further restric-
tion of tinman expression to the cardiac progenitors, in
which it will persist throughout development, involves
the secreted segmentation gene product encoded by
wingless (wg, a Drosophila Wnt gene). Here, we show
that strong early expression depends on the synergistic
action of an enhancer element at the 5* end of the gene
in conjunction with an element in the first intron. More-
over, two distinct enhancer regions are responsible for
tinman expression in the heart: one region confers ex-
pression in the heat tube associated pericardial cells,
the other element drives expression in the contractile,
myocardial cells. The latter element contains two CREB
consensus binding sites that are essential for cardiac-
specific expression. genesis 26:55–66, 2000.
© 2000 Wiley-Liss, Inc.
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INTRODUCTION
The molecular processes involved in mesoderm determi-
nation and muscle subtype specification have been stud-
ied in some detail (for review see Abmayr et al., 1995;
Baylies et al., 1998; Bodmer and Frasch, 1999). Specific
gene functions have been identified that act during dis-
crete steps of mesoderm differentiation. As a conse-
quence, models of hierarchical networks of genetic in-
teractions have been proposed to govern the sequential
embryological events in mesoderm differentiation (for
review see Bodmer and Frasch, 1999). At the top of the
hierarchy is twist, which encodes a basic-helix-loop-he-
lix protein (Thisse et al., 1988) and acts as the first
zygotic determinant of mesoderm formation. At blasto-
derm, twist activates the early pan-mesodermal expres-
sion of a number of genes, including the homeobox gene
tinman (Bodmer et al., 1990; Yin et al., 1997), the zinc
finger and homeobox gene zfh-1 (Lai et al., 1991), the
MADS-box gene Dmef2 (Nguyen et al., 1994; Lilly et al.,
1994; Cripps et al., 1998; Nguyen and Xu, 1998), and
FGF-receptor encoded heartless (Shishido et al., 1993).
Although each of these genes plays a crucial role in
mesoderm differentiation and each is first activated at a
similar time point at blastoderm, their mesodermal ex-
pression patterns later in development are distinct from
one another and their functions affect different pro-
cesses of differentiation. For example, the FGF receptor
encoded by heartless is primarily required for dorsal
migration of the mesoderm (Beiman et al., 1996; Gissel-
brecht et al., 1996; Shishido et al., 1997). By contrast,
tinman is not required for this process of migration but
rather for specifying the differentiation pathway of the
dorsal portion of the mesoderm. Without tinman, most
if not all derivatives of the dorsal mesoderm fail to
develop, in particular the heart and visceral muscles
(Bodmer, 1993; Azpiazu and Frasch, 1993). Dmef2, on
the other hand, appears to function in the myogenic-
specific differentiation of all muscles (Bour et al., 1995;
Lilly et al., 1995; Ranganayakulu et al., 1995), rather than
in the earlier specification of mesodermal subdivision or
subsets of cells, as tinman and zfh-1 are (Bodmer, 1993;
Azpiazu and Frasch, 1993; Lai et al., 1993; Broihier et al.,
1998; Su et al., 1999).
In addition to mesoderm endogenous transcription
factors, inductive mechanisms involving signals from the
ectoderm are important for providing spatial information
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in mesodermal subtype specification. The TGF-b factor
encoded by decapentaplegic (dpp) is expressed in a
broad dorsal domain of the ectoderm along the anterior-
posterior axis. Dpp is secreted from the dorsal ectoderm
and is necessary to maintain tinman and Dmef2 expres-
sion in the dorsal mesoderm (Staehling-Hampton et al.,
1994; Frasch, 1995; Xu et al., 1998; Nguyen and Xu,
1998). In addition to the dorsal-ventral patterning role of
dpp, the secreted segment polarity gene products en-
coded by wingless (wg) and hedgehog (hh) are also
crucial for anterior-posterior patterning of the develop-
ing mesoderm (Wu et al., 1995; Baylies et al., 1995;
Lawrence et al., 1995; Azpiazu et al., 1996; Ranganay-
akulu et al., 1996; Park et al., 1996; Riechmann et al.,
1997; for review see Bodmer and Frasch, 1999).
Whereas dpp and tinman are essential for both heart
and visceral mesoderm formation, wg is needed primar-
ily for the cardiac component (Wu et al., 1995). Al-
though the intersection of wg and dpp signaling in the
context of dorsal mesodermal tinman expression ap-
pears to be instructive for cardiac cell type specification
(W.K. Lockwood and R. Bodmer, unpublished data),
other combinations of inductive signals and mesodermal
context factors are likely to be involved in specifying
other mesodermal subset of cells or contribute to further
distinctions between individual cell types (see for exam-
ple, Su et al., 1999).
Here, we show that the dynamic pattern of tinman
expression in the mesoderm is regulated by a modular
set of cis-regulatory elements. High levels of the early
pan-mesodermal expression of tinman depends on the
synergistic interaction between a 350 bp element 59 to
the coding region (Lee et al., 1997) and an element in
the first intron (Yin et al., 1997). tinman expression in
the heart precursors seems to be regulated by two sep-
arate elements in the 39 region of the gene: One element
directs expression to the pericardial cells (as well as in a
subset of visceral circular muscles); the other element
directs expression primarily in the myocardial cells of
the heart. The myocardial-specific expression depends
on two CREB consensus binding sites. We discuss the
possible function of these sites as potential Dpp re-
sponse elements.
RESULTS
Cis-Regulatory Elements Reflect Endogenous
tinman Expression
Endogenous Tinman protein expression in the meso-
derm is detected in four progressively restricted phases
(Fig. 1B–E): first it is present in all the trunk mesoderm
at gastrulation and during germ band extension (stage
8/9), at stage 10 it is restricted to the dorsal mesoderm,
at stage 11/12 it is further restricted to the cardiac
mesoderm and a subset of visceral mesoderm, and finally
after stage 14 is confined to the developing heart (see
also Yin et al., 1997).
In order to study the regulation of tinman expression,
we generated transgenic flies with various genomic frag-
ments of the tinman gene fused to the lacZ reporter
gene (Fig. 1A). A large BamHI fragment (2A) that extends
from about 27 kb into the first intron shows expression
throughout the early mesoderm (Fig. 1F). A fragment 39
to 2A which contains the second intron (42), the third
exon and some 39 untranslated (39 UTR) and noncoding
regions (34) shows expression in the pericardial cells of
the heart and a subset of visceral mesoderm (Fig. 1H; see
also Fig. 3). A 1.4 fragment 39 to 34 contains a myocar-
dial-specific enhancer (73; Fig. 1I). The 39-most fragment
we examined for reporter gene expression contains (at
least part of) the dorsal mesodermal enhancer (Fig. 1G;
see also Xu et al., 1998). The early mesoderm and heart
enhancers have been further studied (see below).
Early Mesodermal Expression Depends On Two
Distinct Elements
Although the large fragment 2A confers early mesoder-
mal expression, all fragments 59 to the coding region
without the first intron fail to show significant lacZ
expression in the mesoderm (Fig. 2A, B). Weak to mod-
erate expression in the early mesoderm is observed
when the first intron itself is examined (Fig. 2C; see also
Yin et al., 1997). However, a significant increase in lacZ
expression is observed when the first intron is combined
with a 350 bp element from the 59 region (or a larger
region containing that element) in the same construct
(Fig. 2A, D, E). Interestingly, both of these elements
contain a number of putative Twist binding sites (Yin et
al., 1997; Lee et al., 1997). Thus, it appears that an
element 59 to the coding region cooperates with an
intronic element to direct the early twist-dependent ex-
pression of tinman.
Pericardial and Visceral Mesoderm Enhancer
tinman
We wanted to further define the pericardial and visceral
mesoderm expression exhibited by fragment 34 in the 39
region of the tinman gene (Fig. 1A, H). Surprisingly, the
pericardial nor the visceral mesoderm expression of frag-
ment 34 cannot be localized to a unique non-protein
coding region: We tested the second intron (construct
42), the 39 UTR and the region 39 to the gene (103A500),
but none of them show expression of all or part of the 34
pattern (Fig. 3A; data not shown). Only the subfragment
56 that contains protein coding sequence 39 to the ho-
meodomain shows 34-like pericardial and visceral meso-
derm expression (Fig. 3B,C). Thus, it is likely that this 39
protein-coding region is necessary for pericardial and
visceral mesoderm expression. However, we do not yet
know if this is the only element needed or if other
regions within fragment 56 are also necessary. Although
tinman RNA does not persist in the forming visceral
mesoderm past stage 11, Tinman protein is present in a
segmented pattern until stage 13 (Fig. 4D). Thus, part of
Tinman’s expression in the visceral mesoderm seems to
be encoded by an element that is linked to or overlaps
with the pericardial element.
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Myocardial Heart Cell Enhancer Maps to an
Element 3* of the Coding Region
Expression of fragment 73 (1.4 kb) is restricted exclu-
sively to the myocardial cells of the forming heart and
directs lacZ expression from stage 12 on. As Tinman
protein, lacZ expression is confined to four of the six
myocardial cells within each hemisegment (Fig. 1E, I).
Unlike Tinman protein, however, no pericardial cell ex-
pression is detected with this construct. Thus, it seems
that myocardial and pericardial expression is regulated
by enhancer elements that act independently from one
another.
To determine the minimal size of this myocardial heart
enhancer of tinman, we examined 600 bp overlapping
fragments derived from construct 73 (fragments
103A–C; Fig. 4A). Even though fragment 103A overlaps
with 103C for only 22 bp (300bp with 103B), transgenic
embryos of all three fragments (103A–C) exhibit lacZ
reporter gene expression in the myocardial cells (Fig.
4B–D). Interestingly however, the level of expression
along the anterior posterior axis varies significantly be-
tween the constructs 103A to 103C. Whereas fragment
103B mediate uniformly strong expression (as is frag-
ment 73, Fig. 4C), fragment 103A promotes strong ex-
pression only in the anterior myocardial cells, which
gradually diminishes posteriorly (Fig. 4B). Conversely,
fragment 103C mediates strong expression posteriorly,
which gradually lessens anteriorly (Fig. 4D).
In order to characterize the myocardial heart cell en-
hancer fragment further, we examined the lacZ reporter
pattern of two slightly out of register fragments that span
the small overlap between 103A and 103C (Fig. 4A): a
305bp fragment (Henh1) and a 360bp fragment
(Henh2). Two copies of Henh1 (23) driving lacZ con-
fers high levels of cardiac-specific expression beginning
at late stage 11 (Fig. 4E–H). However, reporter gene
expression is no longer restricted to the Tinman subset
of myocardial heart cells that is marked by 103B and 73;
rather all myocardial and the pericardial cells are anti-b-
galactosidase positive with this construct (Fig. 4E-G),
including the two cells per hemisegment that do not
normally express tinman. Although the expanded por-
tion of expression within the developing heart is not as
strong as the 103B pattern (Fig. 4E), this pan-cardiac
expansion was never observed in embryos of any of the
103B (or 73) transformant lines (Fig. 4C or 1I). Transfor-
mants with one copy of the Henh1 (13) construct
shows a similar pattern of pan-cardiac expression as
Henh1(23), but exhibits weaker “ectopic” expression
(data not shown). Cardiac expression seems to be some-
what dosage sensitive, these data suggest that the 305 bp
Henh1 fragment is likely to be missing negative control
elements that suppress expression in pericardial and a
subset of myocardial cells. Transformants of Henh2 driv-
ing lacZ show a similar cardiac pattern as Henh1, but the
ectopic cardiac expression (in Tinman-negative myocar-
dial cells and in pericardial cells) is less pronounced than
with Henh2 (Fig. 4A and data not shown). Thus, one of
the negative elements necessary for correct myocardial
expression is likely to be located in the 100 bp region 39
of the Henh1 sequence (see Fig. 4A).
Myocardial Heart Enhancer Activity Depends on
CREB Consensus Binding Sites
We have identified a 600 bp myocardial heart cell en-
hancer (103B) 39 to the tinman coding region, and have
shown that much of the regulatory information for myo-
cardial expression must be contained within the 255 bp
overlap between Henh1 and Henh2 region. Although the
restriction of tinman expression to the cardiac meso-
derm appears to be directed by the changing patterns of
wg and dpp intersects (Wu et al., 1995; Frasch 1995; W.
Lockwood and R. Bodmer, unpublished data), we did
not find any consensus binding sites of known wg re-
sponse element within this genomic region. We did,
however, identify two CRE consensus sites within the
255 bp overlap between Henh1 and 2 (Fig. 4A and Fig.
5A). A consensus binding site for CREB has previously
been shown to be dpp responsive sequence within a
visceral mesoderm enhancer of the Ultrabithorax (Ubx)
(Eresh et al., 1997; Riese et al., 1997). In order to
determine if the CRE consensus sites common to Hen1
and 2 are required for cardiac-specific expression, we
mutated both CRE sites in Henh1 (CRE-M) and examined
lacZ expression in transgenic flies (Fig. 5A). In contrast
to the wild-type form of Henh1(1x) (Fig. 5B), CRE
mutated Henh1(CRE-M) abolishes all heart-specific re-
porter gene expression in all embryos of the four inde-
pendent transformants (Fig. 5C), except in one case
where very weak pericardial expression is observed at
late developmental stages (after the heart tube has
formed, data not shown). We conclude that one or both
of the CRE consensus sequences in tinman myocardial
heart cell enhancer are necessary for cardiac-specific
expression.
DISCUSSION
tinman expression seems to be regulated by discrete
enhancer elements that are distributed 59 to, 39 to and
within the tinman coding region (Yin et al., 1997; Lee et
al., 1997; this study). It has previously been reported
that the twist-dependent tinman expression in the early
mesoderm is achieved by an element within the first
intron (Yin et al., 1997). In addition to confirming this
result, we find that the combination of the first intron
with an element 59 to the tinman coding region (con-
struct 76) results in higher levels of reporter gene ex-
pression are achieved than with the first intron alone
(Fig. 2). This suggests that a composite enhancer ele-
ment is directing high levels of tinman expression in the
early mesoderm.
Later, when tinman expression is restricted to the
developing heart, expression in the forming cardial and
pericardial cells is apparently regulated by separate en-
hancer elements (Figs. 3 and 4). It is noted, however,
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that pericardial expression observed in fragment 56
transformants does not occur in blocks of four out six
cells per hemisegment, as is observed for Tinman pro-
tein (Fig. 1E), but seems to be present in all pericardial
cells. Pericardial expression of fragment 56 transfor-
mants is accompanied by expression in a subset of vis-
ceral mesoderm. A 59 region has also been reported to
confer visceral mesoderm expression (Lee et al., 1997),
although we were unable to detect mesoderm-specific
expression with any 59 fragment by itself (Fig. 2A, B). It
is thus possible that the control of unique pericardial and
visceral mesoderm expression is dispersed and contrib-
uting elements are distributed among various regions of
the tinman gene. Composite regulatory elements that
contribute to overlapping expression patterns have been
observed for other genes, for example even-skipped (Fu-
jioka et al., 1999) and Dmef2 (Nguyen and Xu, 1998).
The wg pathway appears to be specifically required
for heart precursor formation and for the final confine-
ment of tinman expression to the cardiac mesoderm
(Wu et al., 1995; Park et al., 1996). However, wg re-
sponsive elements have not been identified, i.e., dTCF
consensus sites (Riese et al., 1997; van de Wetering,
1997), neither in the pericardial nor the myocardial
elements. Thus, the wg pathway responsible for heart
formation may act (directly or indirectly) via dTCF-inde-
pendent binding sites and may employ transcription
factor(s) other than dTCF. Moreover, expression of tin-
man in response to wg may require additional, as yet
unidentified transcription factors, which may influence
tinman expression via their own elements in order to
achieve cardiac specificity.
Although dpp is required for maintaining tinman ex-
pression within the dorsal mesoderm, which in turn is
essential for both cardiac and visceral mesoderm forma-
tion (Staehling-Hampton et al., 1994; Frasch, 1995), it
seems that dpp is needed again later, along with wg, to
specify cardiac mesoderm at locations of persistent wg/
dpp overlap. In support of this hypothesis, overexpres-
sion of dpp generates cardiac-specific marker gene ex-
pression at the wg/dpp intersects of the ventrolateral
mesodermal cells (W.K. Lockwood and R. Bodmer, un-
published data). Thus, it is possible that normally the
dpp pathway directly regulates this heart enhancer, in
addition to the dorsal mesoderm enhancer (Xu et al.,
1998). The myocardial heart enhancer apparently does
not contain consensus DNA binding sites for Smad pro-
teins, as does the dorsal mesoderm enhancer (Xu et al.,
1998), but rather depends on two CRE consensus sites.
Mutating these CRE sites abolishes reporter gene expres-
sion conferred by this heart enhancer (Fig. 5). We do not
know if or how the CRE sites of this enhancer are
regulated by the dpp pathway and/or by CREB proteins.
In the case of the midgut enhancer of Ubx, it had been
shown that CRE sites act as dpp response elements
(Riese et al., 1997; Eresh et al., 1997). Moreover, over-
expression of a dominant-negative form of the dCREB-B
transcription factor suppresses the dpp response of this
midgut enhancer, suggesting dpp signaling may normally
modify dCREB activity or that of its partner (Eresh et al.,
1997). In contrast, a CREB binding protein (dCBP) also
binds dTCF in vitro (a wg-dependent transcription fac-
tor) and dCBP mutants interacts genetically with the wg
pathway in the midgut enhancer assay (Waltzer and
Bienz, 1998). Therefore, it is possible that CREB proteins
interact with the dpp or the wg pathway (or both) in
regulating a heart enhancer of tinman. It will be inter-
esting to see if mutant version of a dCREB and/or a dCBP
affect myocardial tinman expression and/or heart for-
mation.
Six vertebrate homologs of tinman have been identi-
fied thus far (Bodmer, 1995; Harvey, 1996; Bodmer and
Venkatesh, 1998), some of which exhibit an expression
pattern that is remarkably similar to the cardiac re-
stricted expression pattern of tinman. Of these, Nkx2-5
has been most extensively studied from Amphioxus to
humans (Komuro and Izumo, 1993; Lints et al., 1993;
Lyons et al., 1995; Lee et al., 1996; Schott et al., 1998;
Tanaka et al., 1999; T.V.Venkatesh and R. Bodmer, un-
published data). Nkx2-5 is the first of the tinman ho-
mologs to be expressed in the bilaterally symmetrical
cardiogenic regions of the anterior lateral plate meso-
derm. The regulation of both tinman and Nkx2-5 ap-
pears to be encoded in a modular fashion in that spatially
separate enhancers direct expression to different parts
of the heart and its precursors (Yin et al., 1997; Xu et al.,
1998; Searcy et al., 1998; Lien et al., 1999; Reecy et al.,
1999; Tanaka et al., 1999; this study). The genomic
distribution of the enhancers, however, seems to be
different between tinman and Nkx2-5: tinman expres-
sion primarily depends on enhancer elements that are
located either within or 39 to the coding region, whereas
the regulatory elements of Nkx2-5 that have been iden-
tified so far appear to be located in the 59 region, except
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FIG 1. Tinman protein and regulation of tinman expression. (A) Map
of fragments from the of the tinman gene that regulate four discrete
patterns of expression. B: BamHI, H: HindIII, R: EcoRI, N: NheI, C:
Cla I, X: Xho I, EM: early mesoderm, DM: dorsal mesoderm, VM:
visceral mesoderm, PC: pericardial heart cells, CC: myocardial heart
cells. Black bars indicate exons. (B–E) Tinman protein. (B) Stage 9
embryo showing Tinman localization in all trunk mesoderm nuclei
(arrowheads). (C) Stage 10 embryo showing restriction of Tinman to
the dorsal mesoderm (arrowheads). (D) Stage 11/12 embryo show-
ing Tinman in the cardiac (arrowheads) and visceral (arrows) meso-
derm. (E) Stage 15/16 embryo showing Tinman in myocardial (ar-
rowheads) and pericardial (arrows) cells of the newly assembled
heart tube. Note that only four out of six cells per hemisegment are
positive. (F–I) lacZ reporter gene expression visualized with anti-??-
gal antibodies. Due to the perdurance of b-gal, anti-b-gal staining is
observed beyond the presence of endogenous Tinman protein. (F)
Construct 2A driving lacZ reporter gene expression in the early
mesoderm (arrowheads, stage 10 embryo). (G) Construct 103E
driving lacZ in the dorsal mesoderm (arrowheads, stage 11 embryo).
(H) Construct 34 driving lacZ in pericardial cells (arrowheads) and
visceral mesoderm (not shown in this focal plane, stage 15/16
embryo). (I) Construct 73 driving lacZ in the myocardial cells of heart
(arrowheads, stage 15/16 embryo). Note the pattern of expression is
similar to the myocardial expression of Tinman (E).
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for one element in the 39 region that causes expression
in the right ventricle of the heart (Tanaka et al., 1999).
Interestingly, both tinman and Nkx2-5 expression in
the precardiac mesoderm are strongly responsive to
Dpp-like TGF-b signals, which originate from adjacent
germ layers (ectoderm and endoderm, respectively;
Staehling-Hampton et al., 1994; Frasch, 1995; Schulthe-
iss et al., 1995; 1997; see also review by Nascone and
FIG 2. Localization of the early mesoderm tinman enhancer to the
first intron (Yin et al., 1997) and 21 kb region. (A) Map and expres-
sion summary of constructs used. (B) Construct 43 driving lacZ
(stage 11 embryo). Note absence of expression in the mesoderm
(asterisks). (C) Intron I containing construct 41 driving lacZ in the
mesoderm (arrowheads, stage 11 embryo). Construct 41 1 44
driving lacZ in the mesoderm (arrowheads, stage 11 embryo). Con-
struct 76 1 FNT driving lacZ (arrowheads, stage 12/13 embryo).
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Mercola, 1995). Since in Drosophila dorsal mesodermal
and cardiac tinman expression appears to be mediated
by Smad and CREB sites, respectively, it will be interest-
ing to see if Nkx2-5 expression also depends on Smad
and/or CREB consensus sites.
MATERIALS AND METHODS
Tinman Antibody Production
In order to generate Tinman protein products in vitro,
DNA fragments to be inserted into expression vectors
were prepared by PCR using the full-length tinman
cDNA as a template. One DNA fragment contained the
full length tinman protein coding region minus the stop
codon (1245 bp, forward primer: 59- CCC GCG GAT CCA
TGT TGC AGC ACC ATC AGC AGC AGG-39, reverse
primer 59-CGA CCC GGG CAT GTG CTG CAT CTG TTG
CTG CTG-39). The other fragment contained a smaller
portion of the tinman coding region that included the
homeodomain-containing 39 end of the gene, also with-
out the stop codon (508 bp, forward primer: 59-CGC
GGA TCC GCG ATG AAG CGA AAG CCT-39, reverse
primer same a for full-length). These constructs were
subcloned into the BamHI and XmaI sites of the pQE30
vector (Qiagen; Chatsworth, CA), which contains an
inducible promoter and a 39 sequence coding for six
histidine residues (63His tag) followed by a stop codon.
Proteins produced by this expression construct contain
this 63His tag which permits their rapid purification
using Ni-NTA chromatography (see below). Both tin-
man inserts were engineered with a 59 BamHI site and a
39 XmaI site for unidirectional cloning. Polymerase chain
reaction (PCR) fragments and the pQE30 vector were
digested with these two restriction enzymes followed by
ligation and transformation into competent JM107 cells.
Transformants were identified by their ability to produce
an appropriately sized protein in response to induction
by isopropyl-b-D-thiogalactopyranoside (IPTG, see be-
low).
Transformants were cultured overnight at 37°C in the
presence of ampicillin and kanamycin. Cells were then
induced with 1 mM IPTG and cultured for an additional
4 h at 37°C. After centrifugation the pelleted cells were
solubilized in guanidine buffer (6 M guanidine HCl, 0.1
M NaH2PO4, 0.01 M Tris HCl, pH 8). Solubilized fusion
proteins were placed on columns containing Ni-NTA
resin that binds the 63His affinity tag. Columns were
washed with 20 volumes guanidine buffer, 20 volumes
buffer B (8 M urea, 0.1 M NaH2PO4, 0.01 M Tris HCl, pH
8) and the 20 volumes buffer C (8 M urea, 0.1 M
NaH2PO4, 0.01 M Tris HCl, pH 6.3). The bound fusion
protein was eluted with an imidazole/urea buffer (250
mM imidazole, 8 M urea, 0.1 M NaH2PO4, 0.01 M Tris
HCl, pH 7.5. Eluted fusion protein was dialyzed using a
step-wise dilution of urea (6 M, 4 M, 2 M, 0 M urea, in 0.5
M NaCl, 0.01% Tween, 0.1% NP40 and 1 mM DTT). The
FIG 3. Analysis of the pericardial/visceral mesoderm tinman en-
hancer. (A) Map and expression summary of constructs used. (B)
Construct 56 driving lacZ double labeled with anti-PC antibodies
(dorsal view of stage 15 embryo). Note the coincidence of lacZ
expression with pericardial cells (arrowheads). (C) Construct 56
driving lacZ in a subset of the visceral mesoderm (arrowheads,
lateral view of stage 13 embryo). (D) Same stage embryos as (C)
showing Tinman expression in visceral mesoderm (arrowheads).
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FIG 4. Analysis of the myocardial tinman enhancer. (A) Map and
expression summary of constructs used. (B–F) Dorsal view of stage
15/16 embryos. (B) Construct 103A driving lacZ preferentially in the
anterior myocardial cells (arrowhead). (C) Construct 103B driving
lacZ strongly in myocardial cells along the entire heart and in the
identical pattern as construct 73 (Fig. 1I). (D) Construct 103C driving
lacZ preferentially in the posterior myocardial cells (arrowhead).
(E–H) Two copies of Henh1 construct driving lacZ. (E) lacZ expres-
sion in all myocardial (arrowheads) and more weakly in all pericardial
cells (arrows) of the heart. Note that the myocardial cells that nor-
mally do not express tinman express lacZ more weakly. (F) Embryo
double-labeled with anti-PC (blue) and anti-b-gal showing the jux-
taposition anti-PC labeled pericardial cells next to strongly lacZ
expressing myocardial cells. (G) Note the coincidence of lacZ
(brown) and Dmef2 expression (blue) in the myocardial cells (arrow-
heads, stage 14 embryo). (H) Note the coincidence of lacZ and
Dmef2 expression in the forming cardiac mesoderm (arrowheads,
stage 11 embryo).
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final solution, which lacked urea, included 20 mM phos-
phate-buffered saline (PBS) (pH 7.5) and 20% glycerol.
Most of the fusion protein remained soluble under these
conditions. Sodium dodecyl sulfate (SDS) gel electro-
phoresis of the solution showed that the majority of the
solubilized protein in all samples migrated as single band
(data not shown). There were a few additional bands
containing relatively insignificant amounts of protein.
(These were later determined to be degradative products
of the Tinman fusion proteins.) Consequently, the pro-
teins used for antibody production were obtained by
preparative SDS gel electrophoresis of the solutions con-
taining the eluted fusion proteins. Regions of polyacryl-
amide gels that contained the primary fusion protein
band were excised and frozen.
Anti-Tinman antibodies were prepared by Immuno-
Dynamics Inc. (La Jolla, CA.). A combination of both the
full-length Tinman fusion protein as well as the smaller
homeodomain-containing protein were used as antigens
in each of two rabbit. Excised gel bands containing
Tinman fusion proteins were injected into rabbits fol-
lowing standard procedures. Animal were boosted four
times and the sera obtained following the final boost was
purified with CM Affi-Gel blue (Bio-Rad; Richmond, CA)
affinity chromatography to produce the protease free
globulin fraction used in these studies.
Generation of Promoter-lacZ Constructs and
Transgenic Flies
Cloning of genomic region of tinman is described in
Bodmer (1993) and Azpiazu and Frasch (1993). Position
21 of the genomic DNA sequence is defined as the base
before the first ATG codon of the open reading frame of
the tinman cDNA (Bodmer et al., 1990). Position 11 is
FIG 5. Mutated CREB consensus
binding sites abolishes cardiac ex-
pression of myocardial heart en-
hancer. (A) Wild-type and mutant se-
quence of CRE1/2-containing
Henh1. (B) Stage 11/12 embryo con-
taining one copy of wild-type Henh1
driving lacZ. Note expression in the
cardiac mesoderm (arrowheads). All
five independent insertions of Henh1
(13 and 23) showed strong expres-
sion in the cardiac mesoderm. (C)
Stage 11/12 embryo containing one
copy of CRE1/2-mutated Henh1 driv-
ing lacZ. Note the lack lacZ expres-
sion in the cardiac mesoderm (aster-
isks). All four independent insertions
of the mutated Henh1 construct
lacked expression in the cardiac me-
soderm.
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defined as first base after the TAG stop codon of the
tinman cDNA. Intron sequences are numbered sepa-
rately.
Construct 2A was made with the 8.0 kb BamHI up-
stream fragment that extends into intron I (see Fig. 1A).
2A was blunted and subcloned into the StuI cloning site
of the vector pWHL, which contains the hsp70-TATA-
box (providing a core promoter) in front of the lacZ
coding region (Ip et al., 1992). Three restriction frag-
ments, 1.4 kb ClaI-NheI (intron I containing construct
41), 0.7 kb NheI-HindIII1 (intron II containing construct
42) and 1.64 kb NheI-EcoRI (construct 34, containing
intron II and 39 coding and noncoding sequences), were
subcloned the same way into pWHL. A 1.0 kb HindIII1-
EcoRI fragment (construct 56) having part of the third
exon, the 39 UTR and some 39 noncoding region was
generated by partially digesting the NheI-EcoRI fragment
with HindIII before subcloning into pWHL. Intron I (807
bp) was also amplified by PCR using plaque-forming
units (pfu) polymerase and primers pairs which had an
overhang of sequences for SphI site. The forward primer
was 59-CCG GCA TGC GTA AGC TTG GAA GTT TTG
AA-39 and the reverse primer was 59-GGC GCA TGC GCA
TGC GCG CTG CGG GAA AGC AG-39. The PCR product
was digested with SphI and cloned into pWHL. The
identity of the constructs was confirmed by sequencing.
Short regions of 59 upstream region were cloned in a
similar way. Construct 75 (21159 to 2959, 202 bp) was
amplified with forward primer 59-GCC GCA TGC TAT
GTA TAT GTG TGT ACT GT-39 and reverse primer 59-
GGC GCA TGC CAC TTG AAA CTG TTA TGA TT-39.
Construct 76 (21159 to 2807, 352 bp) was amplified
using forward primer 59-GCC GCA TGC TAT GTA TAT
GTG TGT ACT GT-39 and reverse primer 59-CGG GCA
TGC GCG TCT TGT GTA TTA AAC GG-39. Construct 77
(2928 to 2801, 120 bp) was amplified by forward
primer 59-GCC GCA TGC TTT AAA CCA AAC ATA TTC
CC-39 and reverse primer 59-CGG GCA TGC GCG TCT
TGT GTA TTA AAC GG-39.
An upstream 2.1 kb genomic ClaI fragment that also
contains part of exon I including position 21 was sub-
cloned into pBSK1. From this subclone, sequences up-
stream of 21 bp (deleting the native ATG) was amplified
using the T7 primer and an internal reverse primer (from
220 to 21, primer sequence 59-TTC GGT ACC CCT CGC
TGT GCG ATC ACT TG-39) with a restriction site over-
hang of KpnI. The PCR product was cut with KpnI and
ClaI and subcloned into pBSK1 (construct 35). The
identity of the PCR product was confirmed by cycle
sequencing. Construct 35 was then digested with KpnI
and BamHI and subcloned into the KpnI-BamHI site of
pCasper-AUG-bgal (Thummel et al., 1988) (construct
44). 59 deletions of construct 35 were made by digesting
with EcoRI and KpnI (construct 49, 21085 to 21) or
PvuII and KpnI (construct 51, 2372 to 21) and ligating
into pCasper-AUG-bgal similar to construct 44. Larger
fragments that included region upstream of the ClaI site
were generated by fusing the different length genomic
fragments into the ClaI site. Constructs 43, 45, and 47
were generated by fusing the BamHI-ClaI, HindIII-ClaI,
and EcoRI-ClaI fragments, respectively, with construct
35 at the ClaI site. All deletions were subcloned into
pCasper-AUG-bgal as KpnI–BamHI or KpnI-EcoRI frag-
ments.
To check the interaction of intron I and 59 upstream
region, intron I containing construct 41) was subcloned
into ClaI site of construct 35 to fuse with upstream
region (construct 41 1 44). To further test the results
from construct 41 1 44, intron I sequences from con-
struct FNT were also fused with construct 51 and 44 at
the PvuII and ClaI sites, respectively, to generate con-
structs FNT 1 51 and FNT 1 44, respectively. Fusions of
construct 76 and the first intron sequences were also
generated. This was achieved by PCR amplification of
region 76 using same forward primer (described above)
but with an overhang of sequences for XbaI and same
reverse primer sequence (described above) with an
overhang of sequences for SphI site. Similarly I intron
sequences were generated by PCR using forward and
reverse primer with an overhang of SphI and XbaI sites.
Both PCR products were purified, digested with SphI
and XbaI, mixed and ligated into SphI site of pWHL, to
generate FNT 1 76. Orientation and the sequence in the
final insert were verified by sequencing.
A 1.4 kb HindIII (1132 to 11524) fragment (H2-H3,
see Fig.1A) of the 39 region was subcloned into StuI site
of pWHL after blunting the ends (construct 73). Primers
(listed below) were made with SphI overhangs and frag-
ments were amplified using pfu polymerase. SphI di-
gested PCR fragments were subcloned into SphI site of
the pWHL vector. Fragment 103A (1132 to 1744, 612
bp) was amplified with 59-GCC GCA TGC AAG CTT AAG
ACC AAT CAG TT-39 (forward) and 59-GGC GCA TGC
CCA ACG CAC TTC CCC TTT CC-39 (reverse), fragment
103A500 (1132 to 1633, 501 bp) with 59-GCC GCA
TGC AAG CTT AAG ACC AAT CAG TT-39 (forward) and
59- GGC GCA TGC GAA TTC GTT TTT CAT AAA AC-39
(reverse), fragment 103B (1402 to 11022, 611 bp) with
59-GCC GCA TGC TCA GCT AAA GAT CAA TCA GA-39
(forward) and 59-GGC GCA TGC CTG CAA CCC CCC
GTT TAC CC-39 (reverse), fragment 103C (1722 to
11232, 530 bp) with 59-GCC GCA TGC AGT GCG TTG
GCG GCA GAC AT-39 (forward) and 59-GGC GCA TGC
TCC AGT AAC TAT TTG ATG TC-39 9 (reverse), fragment
103D (11232 to 11832, 650 bp) with 59-GCC GCA TGC
CGG GTA AAC GGG GGG TTG CA-39 (forward) and
59-GGC GCA TGC TAT AAA ATG TCT TGG CTA AA-39
(reverse), fragment 103E (11332 to 11932, 701 bp)
with 59-CGG GCA TGC GAG ACA TCA AAT AGT TAC
TG-39 (forward) and 59-GGC GCA TGC GGA TCC TCG
ACG GAG GGG CA-39 (reverse), Henh1 (1616bp to
1921bp, 305 bp) with 59-GCC GCA TGC GAA TTC GAA
GGC GAA CGG CA-39 (forward) and 59-GGC GCA TGC
CTC GAG CCC CCA ATG AAA TA-39 (reverse), and
Henh2 (1661 to 1913, 362 bp) with 59-GCC GCA TGC
AAT TGA AAT GTT TTC CCT TT-39 (forward) and 59-
GGC GCA TGC GCT GCA ACC CCC CGT TTA CC-39
(reverse). Two copies of Henh1 (23) were made using
64 VENKATESH ET AL.
the same forward and reverse primers: in one reaction
forward primers with SphI overhang and reverse primer
with XbaI overhang were used, in the other reaction
forward primers with XbaI overhang and reverse prim-
ers with SphI overhang were used. PCR products from
both reactions were purified from gel, digested with
XbaI and SphI, and ligated into SphI site of pWHL (in
head to tail orientation). Mutations in CRE sites of Henh1
were created in two PCR steps using overlapping mutant
oligos and the forward and reverse primers described
above for Henh1. Sequence of the mutant CRE1 oligo
was 59-AGG TTG CAT TTA TGA AAC GTT TAA GTG GTC
GAT ATG C-39 and sequence of the mutant CRE2 oligo
was 59- TCA TAA ATG CAA CCT TTG TAA TGT CAT CGA
CCA ACG CAC T-39 (see Fig. 5A). The first two PCR
products were generated using mutant CRE1 oligo and
reverse Henh1 primer in one PCR reaction and mutant
CRE2 oligo and forward Henh1 primer in another reac-
tion. Both PCR products were separated on an agarose
gel, purified, mixed together, denatured and reannealed.
From this mixture, DNA carrying mutations in both
CREB sites was amplified by the Henh1 forward and
reverse primers. The final PCR product was purified,
sequenced and then subcloned into the SphI site of
pWHL.
Transgenic flies were generated by injecting early blas-
toderm embryos of the genotype w; 1/ 1; 1/ 1 with
the tinman enhancer-lacZ reporter constructs (100 mg/
ml) along with transposase-containing helper plasmid
(50 mg/ml) according to standard procedures (Spradling,
1986; Pirrotta, 1988). Three to six independent transfor-
mants were analyzed for each promoter or enhancer
construct.
Immunocytochemistry
Immunohistochemical staining of fixed embryos was
performed as described (Bodmer, 1993; Su et al., 1998).
Antibodies and dilutions were as follows: anti-Dmef-2
antibodies were used at 1:1,000 (Lilly et al., 1995), anti-
bodies against a pericardial-specific cell surface antigen
were used at 1:10 (Wu et al., 1995; Yarnitzky and Volk,
1995), and affinity-purified mouse or rabbit anti-b-galac-
tosidase antibodies (anti-b-gal) were used at 1:1,000 and
1:4,000, respectively (Cappell; Malverne, PA). For dou-
ble antibody staining the protocol by (Su et al., 1998)
was followed, except that during the color reaction the
substrate for horseradish peroxidase, diaminobenzidine
(Sigma; St. Louis, MO), was used first (brown staining),
followed by the Chromogen (SG substrate kit, Vector
Laboratories; Burlingame, CA) color reaction (blue-gray
staining). For some antibody staining, the ABC Elite kit
(Vector Laboratories) was used to enhance the signal
according to the manufacturer’s instructions.
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